Eat without fear: anti-ige antibody omalizumab, a new weapon against food allergies

#Omalizumab #FoodAllergies #IgE #Anaphylaxis #Immunotherapy  

Food allergies: a persistent therapeutic dead end  

Food allergies affect approximately 10% of children in industrialized countries. Common allergens include peanuts, tree nuts, eggs, and milk. While symptoms are sometimes mild, the risk of severe or even fatal reactions demands strict allergen avoidance and constant vigilance.  

Currently, the only “solution” is total allergen avoidance combined with the use of emergency medication kits. Some forms of oral desensitization exist, but they are lengthy, burdensome, and typically limited to a single allergen. For polysensitized or highly reactive patients, no widely accessible alternative has been available—until now.